5 employees
LamdaGen is a developer of nano-based plasmonic biosensors and robust diagnostic systems.
2004
$1M
from 1 investors over 1 rounds
LamdaGen Corporation raised $1M on June 27, 2019
Investors: National Institute of Allergy and Infectious Diseases (NIAID)